Evaluation of the Effect of Vitamin D on Breast Cancer Development: its Association with Endocrine Functions and Bone Metabolism

Background: Breast cancer remains one of the leading causes of morbidity and mortality among women worldwide, with incidence rates steadily increasing over the past decades. Despite significant advances in early detection and treatment modalities, identifying reliable biomarkers that can predict disease onset, progression, and patient outcomes remains a major clinical challenge. Among the various biological factors under investigation, vitamin D and calcium homeostasis have attracted considerable attention due to their critical roles in cell growth, differentiation, and immune regulation. Objectives: Vitamin D, parathyroid hormone (PTH), estrogen, alkaline phosphatase, correlation levels between the parameters measured, and the receiver operating characteristic curve (ROC) were all examined in this study, which aims to shed light on the role of vitamin D in the development of breast cancer and its relationship to some parameters. Patients and Methods: The patients were divided into three groups. The control group was G1; patients diagnosed early and receiving chemotherapy were G2; and patients receiving surgery or chemotherapy were G3. Results: This study showed that, compared to the control group, the breast cancer groups had lower vitamin D levels, with statistically significant P-values for G1 and G2 for vitamin D and PTH, respectively. The fact that groups of people with breast cancer had significantly low vitamin D levels and high levels of parathyroid hormone supports the idea that vitamin D can fight cancer. Receiver operating characteristic (ROC) curve analysis underscored the diagnostic potential of vitamin D and PTH, both of which demonstrated excellent sensitivity and specificity. Conclusion: Vitamin D and PTH were found to be factors that lead to tumor progression in breast cancer patients in this study. The idea that low vitamin D levels and high parathyroid hormone support the idea that vitamin D fights cancer. Keywords: Breast cancer, Vitamin D, Parathyroid hormone, Calcium level.

Authors

Institutions

Publication Details

Journal
Diyala Journal of Medicine
Published
2026-04-25
DOI
https://doi.org/10.26505/djm.v30i1.1364
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of the Effect of Vitamin D on Breast Cancer Development: its Association with Endocrine Functions and Bone Metabolism

Amer Hasan Abdullah, Abbas Mohammed, Ali Hussein Fadhil, Faez A. Hamza Ashour et al.
Diyala Journal of Medicine
Vitamin D Research Studies
article

Evaluation of the Effect of Vitamin D on Breast Cancer Development: its Association with Endocrine Functions and Bone Metabolism

Amer Hasan Abdullah, Abbas Mohammed, Ali Hussein Fadhil, Faez A. Hamza Ashour, Shahad A. Jarallah
article en

Abstract

Background: Breast cancer remains one of the leading causes of morbidity and mortality among women worldwide, with incidence rates steadily increasing over the past decades. Despite significant advances in early detection and treatment modalities, identifying reliable biomarkers that can predict disease onset, progression, and patient outcomes remains a major clinical challenge. Among the various biological factors under investigation, vitamin D and calcium homeostasis have attracted considerable attention due to their critical roles in cell growth, differentiation, and immune regulation. Objectives: Vitamin D, parathyroid hormone (PTH), estrogen, alkaline phosphatase, correlation levels between the parameters measured, and the receiver operating characteristic curve (ROC) were all examined in this study, which aims to shed light on the role of vitamin D in the development of breast cancer and its relationship to some parameters. Patients and Methods: The patients were divided into three groups. The control group was G1; patients diagnosed early and receiving chemotherapy were G2; and patients receiving surgery or chemotherapy were G3. Results: This study showed that, compared to the control group, the breast cancer groups had lower vitamin D levels, with statistically significant P-values for G1 and G2 for vitamin D and PTH, respectively. The fact that groups of people with breast cancer had significantly low vitamin D levels and high levels of parathyroid hormone supports the idea that vitamin D can fight cancer. Receiver operating characteristic (ROC) curve analysis underscored the diagnostic potential of vitamin D and PTH, both of which demonstrated excellent sensitivity and specificity. Conclusion: Vitamin D and PTH were found to be factors that lead to tumor progression in breast cancer patients in this study. The idea that low vitamin D levels and high parathyroid hormone support the idea that vitamin D fights cancer. Keywords: Breast cancer, Vitamin D, Parathyroid hormone, Calcium level.

Diyala Journal of MedicineVol. 30(1)
University of Baghdad (IQ), Mustansiriyah University (IQ), University of Kerbala (IQ)
Good health and well-being
Openalex Percentile: Top 15%
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.